|
(1R,2S)-rel-2-(丁氧羰基)环丙烷-1-羧酸
|
R175634-1g
|
≥97% |
2055841-08-0 |
1g
|
¥ 1211.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,2R)-rel-2-(4-氯-3-氟苯基)环丙烷-1-羧酸
|
R175633-1g
|
≥97% |
2055841-07-9 |
1g
|
¥ 3465.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,2R)-rel-2-(3-乙氧基-4-氟苯基)环丙烷-1-羧酸
|
R175632-1g
|
≥97% |
2055841-05-7 |
1g
|
¥ 1679.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
rel-甲基(3S,4S)-4-{[((1R)-1-苯基乙基]氨基}氧戊烷-3-羧酸盐
|
R175629-1g
|
≥97% |
2055840-97-4 |
1g
|
¥ 2131.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-(1-甲基哌啶-3-基)甲醇
|
R175599-1g
|
≥97% |
205194-11-2 |
1g
|
¥ 490.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[((3R)-1-[(叔丁氧基)羰基]吡咯烷基-3-基]乙酸
|
R175595-1g
|
≥97% |
204688-60-8 |
1g
|
¥ 37.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[(2R)-1-甲基氮杂环丁烷-2-基]甲胺 双(三氟乙酸)盐
|
R175526-250mg
|
≥97% |
2007919-70-0 |
250mg
|
¥ 7004.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[(3R)-恶烷-3-基]甲胺盐酸盐
|
R175499-250mg
|
≥97% |
2007916-32-5 |
250mg
|
¥ 9561.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-N-{3,6-二氯-1H-吡唑并[3,4-d]嘧啶-4-基}哌啶-3-胺盐酸盐
|
R175497-1g
|
≥97% |
2007916-10-9 |
1g
|
¥ 1679.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1r,4s,6s)-6-叔丁基6-羟基-2-氮杂双环[2.2.1]庚烷-2-羧酸酯
|
R175470-100mg
|
≥97% |
198835-05-1 |
100mg
|
¥ 4553.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
相对于叔丁基(1S,4S,5R)-5-羟基-2-氮杂双环[2.2.1]庚烷-2-羧酸酯
|
R175468-500mg
|
≥97% |
198835-03-9 |
500mg
|
¥ 7004.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,3S,5R)-2-[(叔丁氧基)羰基] -2-氮杂双环[3.1.0]己烷-3-羧酸
|
R175453-1g
|
≥97% |
197142-34-0 |
1g
|
¥ 721.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[(2R)-1-[(1R)-1-苯乙基]氮杂环丁烷-2-基]甲醇
|
R175449-1g
|
≥97% |
1962153-11-2 |
1g
|
¥ 6304.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-[(2R)-吡咯烷-2-基] -2H-1,2,3,4-四唑盐酸盐
|
R175446-1g
|
≥97% |
1956437-95-8 |
1g
|
¥ 735.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
R-121919,CRF1 受体拮抗剂
|
R175432-100mg
|
Moligand™, ≥97% |
195055-03-9 |
100mg
|
¥ 10506.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4R)-4-(羟甲基)-1-[((1R)-1-苯基乙基]吡咯烷丁-2-酮
|
R175359-1g
|
≥97% |
190957-22-3 |
1g
|
¥ 1872.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2R,3R)-2,3-双(苯甲酰氧基)丁二酸,(4S)-4-(3-溴苯基)-6,8-二氯-2-甲基-1,2,3,4-四氢异喹啉
|
R175309-1g
|
≥97% |
1870821-30-9 |
1g
|
¥ 756.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R,4R)-吡咯烷-3,4-二醇
|
R175296-500mg
|
≥97% |
186393-31-7 |
500mg
|
¥ 9911.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-1,3-二甲基哌嗪半草酸酯
|
R175247-500mg
|
≥97% |
1844898-15-2 |
500mg
|
¥ 10506.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4R,5R)-4-[(叔丁基二甲基甲硅烷基)氧基] -5-{[[(叔丁基二甲基甲硅烷基)氧基]甲基} -3-氯氧杂-2-基
|
R175219-1g
|
≥97% |
1820749-52-7 |
1g
|
¥ 5253.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1r,2s,4s)-rel-7-氮杂双环[2.2.1]庚-2-醇盐酸盐
|
R175161-250mg
|
≥97% |
1810070-05-3 |
250mg
|
¥ 12257.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4R)-4-氨基吡咯烷酮-2-盐酸盐
|
R175111-500mg
|
≥97% |
1788058-41-2 |
500mg
|
¥ 11662.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[(1R,2S,5S)-rel-3-氮杂双环[3.1.0]己-2-基]甲醇盐酸盐
|
R175048-1g
|
≥97% |
1788041-43-9 |
1g
|
¥ 4240.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(5R)-5-(氨基甲基)-1,3-恶唑烷丁-2-酮盐酸盐
|
R175043-250mg
|
≥97% |
1788036-27-0 |
250mg
|
¥ 3853.9
|
期货,请咨询 |
|
0 |
阿拉丁 |